Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02651662
Title Study of REGN2810 and REGN1979 in Patients With Lymphoma
Acronym CLIO-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | DEU

Facility Status City State Zip Country Details
Regeneron Research Facility ACTIVE_NOT_RECRUITING Baltimore Maryland 21287 United States Details
Regeneron Research Facility RECRUITING Boston Massachusetts 02215 United States Details
Regeneron Research Facility WITHDRAWN Heidelberg Baden-Wurttemberg 69120 Germany Details
Regeneron Research Facility RECRUITING Barcelona 08035 Spain Details
Regeneron Research Facility ACTIVE_NOT_RECRUITING Madrid 28033 Spain Details
Regeneron Research Facility ACTIVE_NOT_RECRUITING Madrid 28040 Spain Details
Regeneron Research Facility RECRUITING Madrid 28041 Spain Details
Regeneron Research Facility ACTIVE_NOT_RECRUITING Majadahonda 28222 Spain Details
Regeneron Research Facility ACTIVE_NOT_RECRUITING Salamanca 37007 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field